Fupeng Ma

USPTO Granted Patents = 23 (Patent Applications = 7)

CIPO Patents = 1

EPO Patents = 8 (Patent Applications = 8)

Average Co-Inventor Count = 8.5

ph-index = 4

Forward Citations = 93(Granted Patents)

Location History:

Toronto, CA (2010 - 2011)
Cambridge, MA (US) (2012 - 2013)
Melrose, MA (US) (2009 - 2023)

Company Filing History:

Paloma Pharmaceuticals, Inc.

patents

Years Active: 2009-2023

where 'Filed Patents' based on already Granted Patents

23 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11833142 - 3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof (2023-12-05),

2. 11530213 - Naphthyridinone derivatives and their use in the treatment of arrhythmia (2022-12-20),

3. 11427586 - 1,2,4-oxadiazole derivatives as liver X receptor agonists (2022-08-30),

4. 11185537 - 3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof (2021-11-30),

5. 10844055 - Naphthyridinone derivatives and their use in the treatment of arrhythmia (2020-11-24),

6. 10266531 - Naphthyridinone derivatives and their use in the treatment of arrhythmia (2019-04-23),

7. RE46558 - Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis (2017-09-25),

8. 8541432 - Heterobicyclic carboxamides as inhibitors for kinases (2013-09-24),

9. 8501756 - Heterobicyclic carboxamides as inhibitors for kinases (2013-08-06),

10. 8492393 - Heterobicyclic carboxamides as inhibitors for kinases (2013-07-23),

11. 8486954 - Heterobicyclic carboxamides as inhibitors for kinases (2013-07-16),

12. 8431584 - Heterobicyclic carboxamides as inhibitors for kinases (2013-04-30),

13. 8377940 - Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842 (2013-02-19),

14. 8377939 - Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842 (2013-02-19),

15. 8242125 - Heterobicyclic carboxamides as inhibitors for kinases (2012-08-14),

Title: Fupeng Ma: The Innovative Trailblazer from Melrose, MA

Introduction:

Fupeng Ma, a dedicated inventor hailing from Melrose, MA, is renowned for his unwavering commitment to innovation and his insatiable quest for perfection. His relentless drive to push the boundaries of technology has not only left a lasting mark on the industry but has also sparked inspiration among aspiring inventors worldwide.

Latest Patents:

Among Fupeng Ma's impressive portfolio of 23 patents, his recent creations stand out for their groundbreaking advancements in the field of pharmaceuticals. These include the development of "3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof" as well as "Naphthyridinone derivatives for the treatment of arrhythmia." These innovations showcase his prowess in crafting novel solutions to complex medical challenges.

Career Highlights:

Having worked with esteemed companies such as Novartis AG and AstraZeneca AB, Fupeng Ma has garnered a wealth of experience in the pharmaceutical sector. His contributions have not only elevated the research and development capabilities of these organizations but have also propelled the industry forward.

Collaborations:

Throughout his career, Fupeng Ma has collaborated with industry luminaries such as Ian Egle and Abdelmalik Slassi. Together, they have fostered a culture of innovation and teamwork, leading to the successful realization of numerous pioneering projects.

Conclusion:

In conclusion, Fupeng Ma's enduring legacy as an inventive trailblazer is a testament to his passion for innovation and his unwavering dedication to excellence. His impact on the world of technology, particularly in the realm of pharmaceuticals, continues to inspire the next generation of inventors to push the boundaries of what is possible. Fupeng Ma's contributions will undoubtedly shape the landscape of innovation for years to come, leaving an indelible mark on the industry.

This text is generated by artificial intelligence and may not be accurate.